Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities.
Building on expertise in materials science, drug development and formulation, Lyra has developed proprietary technology that is designed to deliver medicines directly precisely and consistently to the affected tissue for sustained periods with a single administration. Our product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, in-office procedure and intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages for the treatment of CRS.
Company Details
- Employees
- 41
- Founded
- -
- Address
- 480 Arsenal St, Watertown,massachusetts 02472,united States
- Phone
- 617.393.4600
- co****@****atx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lyratherapeutics.com
- Keywords
- Pharmaceuticals and Biotechnology.
- HQ
- Watertown, Massachusetts
Lyra Therapeutics Questions
Lyra Therapeutics's helpline number is 617.393.4600
Lyra Therapeutics's website is lyratherapeutics.com
Lyra Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lyra-therapeutics
Lyra Therapeutics has
41 employees.
View email and phone details for 41
employees at Lyra Therapeutics.
Lyra Therapeutics's industry is
Biotechnology Research
Lyra Therapeutics's top competitors are
Lyndra Therapeutics,
Vertex Pharmaceuticals,
Sarepta Therapeutics,
Kymera Therapeutics,
Spyglass Pharma, Inc.,
Moonlake Immunotherapeutics (Nasdaq: Mltx),
Cullinan Therapeutics,
Beam Therapeutics,
Syntis Bio,
Vera Therapeutics, Inc..
Lyra Therapeutics's support email address is contactus@lyratx.com
Lyra Therapeutics's categories are Biotechnology Research
Lyra Therapeutics's founding year is 2018
